Physician profile
Clayton Thomas Hodges
NPI 1154680486
$13,844.86
in general payments reported to CMS, 2019-2025
13 companies · $592 in 2025
The $592 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,621 · 2021: $3,618 · 2022: $3,690 · 2023: $2,629 · 2024: $695 · 2025: $592.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,984 · Food and Beverage: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,983.86 |
| Food and Beverage | $931.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $6,748.92 | 2021-2024 | |
| Sequoia Surgical, INC. | $2,320.00 | 2019-2021 | |
| Smith+Nephew, INC. | $1,494.51 | 2019 | |
| Arthrex, INC. | $1,243.78 | 2023-2024 | |
| Medical Device Business Services, INC. | $1,210.84 | 2019-2023 | Bristow Latarjet |
| Medinc of Texas | $531.49 | 2025 | |
| Stryker Corporation | $120.23 | 2022-2025 | Mako |
| Medtronic, INC. | $60.10 | 2023 | Osteocool Rf Ablation System |
| Bioventus LLC | $34.51 | 2024 | Durolane, Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $31.65 | 2023-2024 | Orthovisc, Monovisc |
| Polynovo North America LLC | $18.93 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $16.93 | 2022 | |
| Therapeuticsmd, INC. | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Hodges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.